JP Patent

JP7728030B2 — 抗老化遺伝子ｋｌｏｔｈｏの発現を誘導する化合物を含む慢性腎疾患の予防または治療用組成物

Assigned to クロトーサイエンシーズカンパニーリミテッド · Expires 2025-08-22 · 1y expired

What this patent protects

Patent listed against Jardiance.

Drugs covered by this patent

Jardiance (empagliflozin) · Boehringer Ingelheim

Patent Metadata

Patent number: JP7728030B2
Jurisdiction: JP
Classification: —
Expires: 2025-08-22
Drug substance claim: No
Drug product claim: No
Assignee: クロトーサイエンシーズカンパニーリミテッド
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.